BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
United Kingdom Intellectual Property Office Decisions |
||
|
You are here: BAILII >> Databases >> United Kingdom Intellectual Property Office Decisions >> Neurim Pharmaceuticals (1991) Ltd (Patent) [2009] UKIntelP o38409 (15 December 2009) URL: http://www.bailii.org/uk/cases/UKIntelP/2009/o38409.html Cite as: [2009] UKIntelP o38409 |
||
[New search] [Printable PDF version] [Help]
For the whole decision click here: o38409
Summary
Neurim Pharmaceuticals (1991) Ltd filed an application for an SPC for the product melatonin, identifying authorisation EU/1/07/392/001 for the medicinal product Circadin - melatonin as the first authorisation to place the product on the market.
However, the Hearing Officer found that an earlier veterinary authorisation for Regulin having the active ingredient melatonin precluded the grant of an SPC based on the later authorisation for Circadin.
Since the conditions of Article 3(d) of the Regulation have therefore not been met, the Hearing Officer rejected the application for an SPC under Article 10(2).
